Patent details

EP2968268 Title: INHIBITORS OF THE ENZYME UDP-GLUCOSE: N-ACYL-SPHINGOSINE GLUCOSYLTRANSFERASE

Basic Information

Publication number:
EP2968268
PCT Application Number:
US2014021984
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP147678627
PCT Publication Number:
WO2014150043
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INHIBITORS OF THE ENZYME UDP-GLUCOSE: N-ACYL-SPHINGOSINE GLUCOSYLTRANSFERASE
French Title of Invention:
INHIBITEURS DE L'ENZYME UDP-GLUCOSE : N-ACYL-SPHINGOSINE GLUCOSYLTRANSFÉRASE
German Title of Invention:
INHIBITOREN DES UDP-GLUCOSE:N-ACYL-SPHINGOSIN-GLUCOSYLTRANSFERASE ENZYMS
SPC Number:

Dates

Filing date:
07/03/2014
Grant date:
29/07/2020
EP Publication Date:
20/01/2016
PCT Publication Date:
25/09/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/07/2020
EP B1 Publication Date:
29/07/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/03/2021
Expiration date:
07/03/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/07/2020
 
 

Name:
Concert Pharmaceuticals Inc.
Address:
65 Hayden Avenue, Suite 3000N, Lexington, MA 02421, United States (US)

Inventor

Name:
HARBESON, Scott L.
Address:
United States (US)

Priority

Priority Number:
201361788946 P
Priority Date:
15/03/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/40; A61P 43/00; C07B 59/00; C07D 403/06; C07D 405/10;

Publication

European Patent Bulletin

Issue number:
202031
Publication date:
29/07/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages